Related references
Note: Only part of the references are listed.Evidence That Diacylglycerol Acyltransferase 1 (DGAT1) Has Dual Membrane Topology in the Endoplasmic Reticulum of HepG2 Cells
Haja R. Wurie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The use of stable-isotopically labeled oleic acid to interrogate lipid assembly in vivo: assessing pharmacological effects in preclinical species
David G. McLaren et al.
JOURNAL OF LIPID RESEARCH (2011)
High-content assays for evaluating cellular and hepatic diacylglycerol acyltransferase activity
Jenson Qi et al.
JOURNAL OF LIPID RESEARCH (2010)
Specific Role for Acyl CoA:Diacylglycerol Acyltransferase 1 (Dgat1) in Hepatic Steatosis Due to Exogenous Fatty Acids
Claudio J. Villanueva et al.
HEPATOLOGY (2009)
Knockdown of Acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice
Ying Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
DGAT enzymes and triacylglycerol biosynthesis
Chi-Liang Eric Yen et al.
JOURNAL OF LIPID RESEARCH (2008)
Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor
Gang Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Diacylglycerol acyltransferases: Potential roles as pharmacological targets
Victor A. Zammit et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance
Cheol Soo Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Reproducibility of stable isotope-labeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics
Faidon Magkos et al.
JOURNAL OF LIPID RESEARCH (2007)
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Kanji Yamaguchi et al.
HEPATOLOGY (2007)
Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice
XX Yu et al.
HEPATOLOGY (2005)
Lipopenia and skin barrier abnormalities in DGAT2-deficient mice
SJ Stone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells
SH Ganji et al.
JOURNAL OF LIPID RESEARCH (2004)
MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine
CLE Yen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities
IJ Waterman et al.
DIABETES (2002)
Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members
S Cases et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat
SJ Smith et al.
NATURE GENETICS (2000)
Share Paper
